Skip to main content
TipRanks
Go Ultimate75% OFF

Avenue Therapeutics (49Y) Q2 2025 Earnings Report

1 Followers

DE:49Y Q2 2025 EPS Results

Actual EPS
EUR 0.09
Consensus EPS
―
Beat/Miss
―
One Year Ago EPS
-EUR 5.65

DE:49Y Q2 2025 Revenue Results

Actual Revenue
EUR 1.23M
Expected Revenue
―
Beat/Miss
―
YoY Revenue Growth
―

Earnings Announcement Details

Quarter
Q2 2025
Date
08/18/2025
Time
TBA
Conference Call
Monday, August 18, 2025

Q2 2025 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q2 2025 Earnings Slide Deck

No slide deck is available for this earnings event.

Q2 2025 Earnings Call Summary

No earnings call summary is available for this earnings event.

DE:49Y Earnings History

DE:49Y earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Nov 17, 20252025 (Q3)―-0.19-1.6988.85% (+1.50)
Aug 18, 20252025 (Q2)―0.09-5.65101.63% (+5.75)
May 19, 20252025 (Q1)―-0.55-13.5495.95% (+12.99)
Mar 25, 20252024 (Q4)-0.50-0.6456.05-101.15% (-56.70)
Nov 14, 20242024 (Q3)-0.83-1.693.96-142.67% (-5.64)
Aug 09, 20242024 (Q2)-0.92-5.65-34.2983.51% (+28.64)
May 15, 20242024 (Q1)-7.91-13.54-90.3485.01% (+76.80)
Mar 18, 20242023 (Q4)-6.5956.058.57553.85% (+47.48)
Nov 13, 20232023 (Q3)-17.153.96-29.67113.33% (+33.63)
Aug 10, 20232023 (Q2)-19.12-34.29-27.26-25.79% (-7.03)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed